Wells Fargo
HALO icon

Wells Fargo’s Halozyme HALO Stock Holding History

Wells Fargo’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-8,500
Closed -$1K – 6430
2019
Q4 		$1K Buy
+8,500
New +$147K ﹤0.01% 6249
2017
Q3 		– Sell
-13,700
Closed -$5K – 6367
2017
Q2 		$5K Buy
+13,700
New +$183K ﹤0.01% 5917
2016
Q3 		– Sell
-280,300
Closed -$91K – 6244
2016
Q2 		$91K Buy
280,300
+18,100
+7% +$179K ﹤0.01% 4889
2016
Q1 		$326K Buy
+262,200
New +$2.47M ﹤0.01% 4126

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Wells Fargo's HALO Position: Q2 2026 in Review

Wells Fargo reduced its Halozyme (HALO) stake by 9.5% in Q2 2026, selling an estimated $9.91M and leaving 1,390,428 shares worth $109M. The position accounts for 0.02% of the portfolio, ranked #652.

Wells Fargo first reported a position in HALO in Q2 2013 and has held it in 53 quarters since. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Wells Fargo held 1,390,428 shares of Halozyme worth $109M as of Q2 2026.
  • Wells Fargo sold 145,309 Halozyme shares in Q2 2026, an estimated $9.91M.
  • Halozyme made up 0.02% of Wells Fargo's portfolio in Q2 2026, its #652 holding.
  • Wells Fargo first reported a position in Halozyme in Q2 2013 and has held it in 53 quarters since.
  • 674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.